Cargando…

Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis

SUMMARY: In a characterization of treatment rates and healthcare costs among patients with an osteoporotic-related fragility fracture overall and by site of care, costs were high and treatment rates were low. PURPOSE: Osteoporotic fractures can be debilitating, even fatal, among older adults. The co...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, A., McClung, M. R., Tran, O., Morrow, C. D., Goldstein, S., Kagan, R., McDermott, M., Yehoshua, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008255/
https://www.ncbi.nlm.nih.gov/pubmed/36905559
http://dx.doi.org/10.1007/s11657-023-01229-7
_version_ 1784905718230417408
author Singer, A.
McClung, M. R.
Tran, O.
Morrow, C. D.
Goldstein, S.
Kagan, R.
McDermott, M.
Yehoshua, A.
author_facet Singer, A.
McClung, M. R.
Tran, O.
Morrow, C. D.
Goldstein, S.
Kagan, R.
McDermott, M.
Yehoshua, A.
author_sort Singer, A.
collection PubMed
description SUMMARY: In a characterization of treatment rates and healthcare costs among patients with an osteoporotic-related fragility fracture overall and by site of care, costs were high and treatment rates were low. PURPOSE: Osteoporotic fractures can be debilitating, even fatal, among older adults. The cost of osteoporosis and related fractures is projected to increase to more than $25 billion by 2025. The objective of this analysis is to characterize disease-related treatment rates and healthcare costs of patients with an osteoporotic fragility fracture overall and by site of fracture diagnosis. METHODS: In this retrospective analysis, individuals with fragility fractures were identified in the Merative MarketScan® Commercial and Medicare Databases among women 50 years of age or older and diagnosed with fragility fracture between 1/1/2013 and 6/30/2018 (earliest fracture diagnosis = index). Cohorts were categorized by clinical site of care where the diagnosis of fragility fracture was made and were continuously followed for 12 months prior to and following index. Sites of care were inpatient admission, outpatient office, outpatient hospital, emergency room hospital, and urgent care. RESULTS: Of the 108,965 eligible patients with fragility fracture (mean age 68.8), most were diagnosed during an inpatient admission or outpatient office visit (42.7%, 31.9%). The mean annual healthcare costs among patients with fragility fracture were $44,311 (± $67,427) and were highest for those diagnosed in an inpatient setting ($71,561 ± $84,072). Compared with other sites of care at fracture diagnosis, patients diagnosed during an inpatient admission also had highest proportion of subsequent fractures (33.2%), osteoporosis diagnosis (27.7%), and osteoporosis therapy (17.2%) during follow-up. CONCLUSION: The site of care for diagnosis of fragility fracture affects treatment rates and healthcare costs. Further studies are needed to determine how attitude or knowledge about osteoporosis treatment or healthcare experiences differ at various clinical sites of care in the medical management of osteoporosis.
format Online
Article
Text
id pubmed-10008255
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-100082552023-03-13 Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis Singer, A. McClung, M. R. Tran, O. Morrow, C. D. Goldstein, S. Kagan, R. McDermott, M. Yehoshua, A. Arch Osteoporos Original Article SUMMARY: In a characterization of treatment rates and healthcare costs among patients with an osteoporotic-related fragility fracture overall and by site of care, costs were high and treatment rates were low. PURPOSE: Osteoporotic fractures can be debilitating, even fatal, among older adults. The cost of osteoporosis and related fractures is projected to increase to more than $25 billion by 2025. The objective of this analysis is to characterize disease-related treatment rates and healthcare costs of patients with an osteoporotic fragility fracture overall and by site of fracture diagnosis. METHODS: In this retrospective analysis, individuals with fragility fractures were identified in the Merative MarketScan® Commercial and Medicare Databases among women 50 years of age or older and diagnosed with fragility fracture between 1/1/2013 and 6/30/2018 (earliest fracture diagnosis = index). Cohorts were categorized by clinical site of care where the diagnosis of fragility fracture was made and were continuously followed for 12 months prior to and following index. Sites of care were inpatient admission, outpatient office, outpatient hospital, emergency room hospital, and urgent care. RESULTS: Of the 108,965 eligible patients with fragility fracture (mean age 68.8), most were diagnosed during an inpatient admission or outpatient office visit (42.7%, 31.9%). The mean annual healthcare costs among patients with fragility fracture were $44,311 (± $67,427) and were highest for those diagnosed in an inpatient setting ($71,561 ± $84,072). Compared with other sites of care at fracture diagnosis, patients diagnosed during an inpatient admission also had highest proportion of subsequent fractures (33.2%), osteoporosis diagnosis (27.7%), and osteoporosis therapy (17.2%) during follow-up. CONCLUSION: The site of care for diagnosis of fragility fracture affects treatment rates and healthcare costs. Further studies are needed to determine how attitude or knowledge about osteoporosis treatment or healthcare experiences differ at various clinical sites of care in the medical management of osteoporosis. Springer London 2023-03-11 2023 /pmc/articles/PMC10008255/ /pubmed/36905559 http://dx.doi.org/10.1007/s11657-023-01229-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Singer, A.
McClung, M. R.
Tran, O.
Morrow, C. D.
Goldstein, S.
Kagan, R.
McDermott, M.
Yehoshua, A.
Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
title Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
title_full Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
title_fullStr Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
title_full_unstemmed Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
title_short Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
title_sort treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008255/
https://www.ncbi.nlm.nih.gov/pubmed/36905559
http://dx.doi.org/10.1007/s11657-023-01229-7
work_keys_str_mv AT singera treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis
AT mcclungmr treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis
AT trano treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis
AT morrowcd treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis
AT goldsteins treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis
AT kaganr treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis
AT mcdermottm treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis
AT yehoshuaa treatmentratesandhealthcarecostsofpatientswithfragilityfracturebysiteofcarearealworlddataanalysis